Why you need to subscribe to NFCR’s new podcast, “All Things Cancer”

Join the conversation on the future of cancer research—first episode drops February 11

2025-02-10

(Press-News.org) Kick-Off Episode with Dr. Margaret Foti, CEO of AACR, Premieres February 11

Bethesda, MD – February 7, 2025 – The National Foundation for Cancer Research (NFCR) is excited to announce the official launch of its groundbreaking new podcast, All Things Cancer, premiering on February 11, 2025. Hosted by NFCR CEO, Sujuan Ba, Ph.D., this compelling series will bring together the entire ecosystem of cancer research—including leading scientists, oncologists, doctors, patient advocates, caregivers, biotech innovators, and survivors—for powerful discussions on the breakthroughs shaping the future of cancer research, treatment, and care.

Don’t miss out—subscribe today on Spotify and be part of the movement transforming cancer research.

The first episode features an exclusive conversation with Dr. Margaret Foti, CEO of the American Association for Cancer Research (AACR), a globally recognized leader in cancer science. In this must-listen debut, Dr. Foti shares her extensive expertise in advancing cancer research, the challenges and opportunities in the field today, and why collaboration is crucial for accelerating progress toward cures.

“With All Things Cancer, NFCR is bridging the gap between the experts leading scientific innovation and the patients and families who need hope and real solutions,” said Dr. Ba. “By featuring researchers, doctors, advocates, and survivors, we’re ensuring that every voice in the fight against cancer is heard. This podcast is for anyone who wants to stay informed, inspired, and engaged in the latest developments in cancer research.”

Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.

Subscribe now to stay up to date on the latest episodes and join the conversation that’s shaping the future of cancer research. Cancer impacts everyone—whether you're a patient, caregiver, advocate, or researcher, this podcast delivers invaluable insights from those on the frontlines of the fight against it. How to Listen and Subscribe All Things Cancer will be published exclusively on Spotify, with new episodes released biweekly.

Be among the first to listen—subscribe today and tune in to the premiere episode featuring Dr. Margaret Foti on February 11!

Click here to listen and subscribe: All Things Cancer on Spotify.

END

ELSE PRESS RELEASES FROM THIS DATE:

Research pinpoints weakness in lung cancer’s defenses

2025-02-10

At a glance: Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. The enzyme, GUK1, supports metabolism in cancer cells to help tumors grow. In the future, GUK1 could become a possible target for lung cancer therapies. Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, and it can shapeshift in unpredictable ways to evade treatment. While researchers have gleaned important insights into the ...

New study highlights healthcare utilization shifts among Long COVID patients in Colorado after diagnosis

2025-02-10

AURORA, Colo. (Feb 10, 2025) – A new study analyzing Long COVID healthcare utilization in Colorado reveals a significant shift from acute care to outpatient services following diagnosis, shedding light on evolving treatment patterns and the broader healthcare burden posed by the condition. The study, published today in BMC Public Health, was conducted using Colorado’s comprehensive All-Payer Claims Database and provides one of the most detailed population-level insights into Long COVID patients to date. Researchers examined utilization patterns of individuals diagnosed with Long COVID between October 2021 and August 2022, tracking them for one-year post-diagnosis. “The ...

Majority of kids who die in mass shootings killed by family members, Stanford Medicine-led study shows

2025-02-10

When U.S. children die in mass shootings, most of the time the perpetrator is a family member, new Stanford Medicine-led research shows. The findings, which will be published online Feb. 10 in JAMA Pediatrics, come from the first analysis of the relationships between mass shooting perpetrators and pediatric victims, those who are younger than 18 years old. “It was surprising that domestic violence was so pervasive, that 59% of kids who died in mass shootings were at the hands of a family member,” said ...

How perception may shape health safety-related assessments

2025-02-10

Perceiving whether another person is a personal health risk requires quickly assessing their trustworthiness. With limited characteristics available, implicit assumptions often influence risk perception. Research in this area has pointed to brain regions that may be involved in perceiving others as untrustworthy or as carriers of sexually transmitted diseases (STDs). However, the relationship between brain activity, perceived trustworthiness of others, and perceived likelihood of acquiring an STD was unclear prior to a recent study published in eNeuro. In the study led by Daniela Mier at ...

Potential new strategy for relieving anxiety

2025-02-10

Understanding the neural circuits that drive anxiety may help researchers discover circuit-specific targets and therefore increase the precision of treatment strategies. Previous studies have separately suggested that increased serotonin levels and the cerebellum may play roles in anxiety. To explore the relationship between these ideas, Pei Chin, from the University of Pennsylvania, and George Augustine, from Temasek Life Sciences Laboratory, probed whether serotonin in the cerebellum causes anxiety behavior in mice. Contrary to previous ...

Scientists develop corrosion-induced electrodes for biomass upgrading

2025-02-10

A research team led by Prof. ZHANG Jian from the Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences (CAS) has utilized metal corrosion to prepare high-performance electrodes, enabling efficient and cost-effective upgrading of bio-based 5-hydroxymethylfurfural (HMF). This study was published in Chem Catalysis. Corrosion is a common phenomenon that can lead to material failure and economic losses. However, researchers are exploring its potential for beneficial applications, particularly in biomass upgrading. Biomass is among the most abundant renewable resources on earth. Through catalytic conversion, ...

Contemporary hormonal contraception and risk of venous thromboembolism

2025-02-10

About The Study: This study showed venous thromboembolism (VTE) risk variation across hormonal contraceptives with highest rates for combined pills, especially those containing third-generation progestins, and no significant difference in risk for intrauterine devices (IUDs) relative to no use. For patches and implants, the increased VTE risk was uncertain due to limited data. Variation in VTE risk across products underscores the importance of personalized contraceptive counseling. Corresponding Author: To contact the corresponding author, Harman Gailan Hassan Yonis, MD, email harman@live.dk. To ...

Victim-shooter relationships in mass shootings involving child victims

2025-02-10

About The Study: The findings of this study indicate that from 2009 through 2020, a child was most likely to be killed in a mass shooting by a parent or family member, rather than a stranger or a peer. While school shootings dominate media coverage, this study suggests that domestic violence plays a larger role in child mass shootings. Corresponding Author: To contact the corresponding author, Stephanie Chao, MD, email sdchao1@stanford.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamapediatrics.2024.6609) Editor’s ...

Health care company payouts favor shareholders, new research shows

2025-02-10

It’s widely recognized that health care is a growing expense for many Americans. However, what health care companies do with their profits — some made through government programs such as Medicare — remains murky. To investigate this question, researchers at Yale School of Medicine (YSM) analyzed financial reports from 92 large U.S. health care companies. The results were published on Feb. 10 in a research letter in JAMA Internal Medicine. The research team focused on U.S. health care companies on the Standard & Poor’s 500 (S&P 500), which follows the 500 largest companies traded on stock exchanges, to ...

Glucose-lowering medications and risk of COPD exacerbations in patients with type 2 diabetes

2025-02-10

About The Study: The results of this comparative effectiveness research study suggest that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a reduced risk of moderate or severe chronic obstructive pulmonary disease (COPD) exacerbations compared with dipeptidyl peptidase 4 inhibitors in adults with type 2 diabetes and active COPD. This may inform prescribing of glucose-lowering medications among patients with type 2 diabetes and active COPD. Corresponding Author: To contact the corresponding author, Elisabetta Patorno, MD, DrPH, email epatorno@bwh.harvard.edu. To access ...

Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo

Why you need to subscribe to NFCR’s new podcast, “All Things Cancer”

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: